US military buys $72 million in outside help for its biotech research
What happened
The US Army's infectious disease research institute just awarded a $72 million contract for scientific and technical support. This means the military will rely on outside contractors to help manage its biotechnology research projects.
Why it matters
The US military's primary infectious disease research lab, USAMRIID, needs extensive scientific and technical support to operate. This contract ensures they have the staff and project management to continue their work on biodefense and emerging pathogens. It shows a sustained commitment to outsourcing specialized R&D capabilities rather than building them all in-house.
The signal
Watch for future contracts of this size and scope, which would indicate a long-term strategy of externalizing core R&D support functions across military research.